Determinability of model parameters in a two-stage deterministic cancer model

Mathematical Biosciences

Volumn 146, Issue 1, 1997, Pages 1-13

  Wiarda, D ^a   Travis, C C ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CANCER MODEL; CELL DEATH; CELL TRANSFORMATION; GENE MUTATION; MITOSIS RATE; PAPILLOMA; SKIN CANCER; SKIN CARCINOGENESIS; TUMOR GROWTH;

ANIMALS; COCARCINOGENESIS; MATHEMATICS; MICE; MODELS, BIOLOGICAL; PAPILLOMA; SKIN NEOPLASMS;

EID: 0030876427     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(97)00025-4     Document Type: Article

References (19)

1. S. H. Moolgavkar and D. Venzon, Two-event models for carcinogenesis: incidence curves for childhood and adult tumor. Math. Biosci. 47:55-77 (1979).
2. S. M. Cohen and L. B. Ellwein, Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modelling of the ED01 study. Toxicol. Appl. Pharmacol. 104:79-93 (1990).
3. C. C. Travis, T. W. McClain, and P. D. Birkner, Diethylnitrosamine-induced hepatocarcinogenesis in rats: a theoretical study. Toxicol. Appl. Pharmacol. 109:289-304 (1991).
4. C. C. Travis, Chenxin Zeng, and J. Nicholas, A biological model of ED01 hepatocarcinogenesis. Toxicol. Appl. Pharmacol. 140:19-29 (1996).
5. S. H. Moolgavkar, A. Dewanji, and D. J. Venzen, A stochastic two-stage model for cancer risk assessment I: the hazard function and the probability of tumor. Risk Anal. 8(3):383-392 (1988).
6. A. Kopp-Schneider and C. J. Portier, Birth and death/differentiation rates of papillomas in mouse skin. Carcinogenesis 13(6):973-978 (1992).
7. R. B. Conolly and J. S. Kimbell, Computer simulation of cell growth governed by stochastic processes: application to clonal growth cancer models. Toxicol. Appl. Pharmacol. 124:284-295 (1994).
8. L. G. Hanin and A. Yu. Yakovlev, A nonidentifiability aspect of the two-stage model of carcinogenesis. Risk Anal. 16:711-715 (1996).
9. S. Karlin and H. M. Taylor, A First Course in Stochastic Processes. Academic Press, New York, 1975.
10. T. J. Slaga, Mechanisms involved in two-stage carcinogenesis in mouse skin. In Mechanisms of Tumor Promotion, Vol. 2: Tumor Promotion and Skin Carcinogenesis, T. J. Slaga, ed., CRC Press, 1984.
11. H. Hennings, R. Shores, P. Mitchell, E. F. Spangler, and S. H. Yuspa, Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 6(11):1607-1610(1985).
12. H. Loehrke, J. Schweizer, E. Dederer, B. Hesse, G. Rosenkranz, and K. Goerttler, On the persistence of tumor initiation in two-stage carcinogenesis on mouse skin. Carcinogenesis 4:771-775 (1983).
13. O. D. Laerum and O. H. Iversen, eds., Biology of Skin Cancer. Vol. 63 of UICC Technical Report Series, UICC, 1981.
14. C. M. Aldaz, C. J. Conti, I. B. Gimenez, T. J. Slaga, and A. J. P. Klein-Szanto, Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Cancer Res. 45:2753-2759 (1985).
15. M. W. Ewing, C. J. Conti, F. H. Kruszewski, T. J. Slage, and J. DiGiovanni, Tumor progression in SENCAR mouse skin as a function of initiator dose and promotor dose, duration and type. Cancer Res. 48:7048-7054 (1988).
16. G. Fuerstenberg and A. Kopp-Schneider, Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin. Carcinogenesis 1995:61-69 (1995).
17. C. M. Aldaz, C. J. Conti, A. Chen, A. Bianchi, S. B. Walker, and J. DiGiovanni, Promotor independence as a feature of most skin papillomas in SENCAR mice. Cancer Res. 51:1045-1050 (1991).
18. A. Kopp-Schneider and C. J. Portier, Carcinoma formation in NMRI mouse skin painting studies is a process suggesting greater than two stages. Carcinogenesis 16:53-59 (1995).
19. Deleted in proof.